Literature DB >> 20202577

Gastroesophageal reflux disease and obesity.

Girish Anand1, Philip O Katz.   

Abstract

Gastroesophageal reflux disease (GERD) is a common condition, with multifactorial pathogenesis, affecting up to 40% of the population. Obesity is also common. Obesity and GERD are clearly related, both from a prevalence and causality association. GERD symptoms increase in severity when people gain weight. Obese patients tend to have more severe erosive esophagitis and obesity is a risk factor for the development of Barrett's esophagus and adenocarcinoma of the esophagus. Patients report improvement in GERD when they lose weight and there are several reports suggesting a decrease in GERD symptoms after bariatric surgery. At present, there is little evidence that obesity has any effect on the efficacy of antisecretory therapy, with conflicting data on surgical outcomes. This review attempts to put in perspective the relationship of these two common entities. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20202577     DOI: 10.1016/j.gtc.2009.12.002

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  21 in total

Review 1.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.

Authors:  William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-30       Impact factor: 4.254

Review 3.  Patients Having Bariatric Surgery: Surgical Options in Morbidly Obese Patients with Barrett's Esophagus.

Authors:  I Braghetto; A Csendes
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 4.  Gastroesophageal reflux disease in children and adolescents: when and how to treat.

Authors:  Matthew W Carroll; Kevan Jacobson
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

5.  The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists.

Authors:  Ryan T Hurt; Christopher Kulisek; Laura A Buchanan; Stephen A McClave
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

6.  Laparoscopic fundoplication takedown with conversion to Roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure.

Authors:  Dimitrios Stefanidis; Fernando Navarro; Vedra A Augenstein; Keith S Gersin; B Todd Heniford
Journal:  Surg Endosc       Date:  2012-06-13       Impact factor: 4.584

Review 7.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

8.  Vagal afferent innervation of the lower esophageal sphincter.

Authors:  Terry L Powley; Elizabeth A Baronowsky; Jared M Gilbert; Cherie N Hudson; Felecia N Martin; Jacqueline K Mason; Jennifer L McAdams; Robert J Phillips
Journal:  Auton Neurosci       Date:  2013-04-11       Impact factor: 3.145

9.  High prevalence of esophageal dysmotility in asymptomatic obese patients.

Authors:  Justin Côté-Daigneault; Pierre Leclerc; Josette Joubert; Mickael Bouin
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06

10.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.